Super jazzed that Anish and I got to hear from John Norris from HSBC. While we're in a bit of turbulence right now for the public markets, John pointed out how we (and biotech specifically) are witnessing a tale of 2 cities the 'have and have nots'. John talks about this divergence, insider rounds supporting ventures, a potential looming cliff for some, the tailwinds for biotech/biopharma ventures, and possible outcomes for how all this might play out. NB: This episode was originally recorded in March 2024.